Cephalon (CEPH) volatility flat into EPS and generic drug competition outlook
Tweet Send to a Friend
Cephalon (Nasdaq: CEPH) closed at $59.22. CEPH is expected to report Q2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
